MIF and neoplasm: Targeting MIF signaling for therapeutic purposes has emerged as a promising approach in oncology and virology, given its crucial role in tumor progression, viral persistence, and immunoregulation (Table 1), although current data are mostly based on oncovirus-negative cancers.